Fig. 1
From: Clinical course of 63 patients with neonatal onset urea cycle disorders in the years 2001–2013
Flow chart of screened patients with exclusion criteria and final size of study population. ASSD: Argininosuccinate synthetase deficiency, ASLD: Argininosuccinate lyase deficiency, CPS1D: Carbamoyl phosphate synthetase 1 deficiency, HE: Hyperammonemic event, N: Number, OTCD: Ornithine transcarbamylase deficiency, SELICA: Safety & Efficacy of Liver Cell Application, study on liver cell transplantation as treatment option for severe metabolic disorders in patients with UCDs. *These patients would have been eligible for this study but were only recorded on the screening log and not documented in the database